Alıntılar

APA (7. basım) Alıntı
MacManus, M. P., Seymour, J. F., Tsang, H., Fisher, R., Keane, C., Sabdia, M. B., . . . Tobin, J. W. (2024). Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphomaResearch in context. Elsevier.
Chicago Style (17. basım) Atıf
MacManus, Michael P., et al. Adjuvant Rituximab and Elevated Intratumoural CD8 Expression Are Associated with Sustained Disease Control After Radiotherapy in a Randomised Trial of Systemic Therapy in Early-stage Follicular LymphomaResearch in Context. Elsevier, 2024.
MLA (9th ed.) Atıf
MacManus, Michael P., et al. Adjuvant Rituximab and Elevated Intratumoural CD8 Expression Are Associated with Sustained Disease Control After Radiotherapy in a Randomised Trial of Systemic Therapy in Early-stage Follicular LymphomaResearch in Context. Elsevier, 2024.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..